Naratriptan
| Use attributes for filter ! | |
| Molar mass | 335. 465 g/mol |
|---|---|
| CAS ID | 121679-13-8 |
| Bioavailability | 74% |
| Formula | C17H25N3O2S |
| Trade name | Amerge, Naramig, others |
| Metabolism | Hepatic |
| Music groups | Sumatriptan |
| Rizatriptan | |
| Zolmitriptan | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951364 |
About Naratriptan
Naratriptan is a triptan drug marketed by GlaxoSmithKline and is used for the treatment of migraine headaches. It is a selective 5-HT₁ receptor subtype agonist. It was patented in 1987 and approved for medical use in 1997.